P. Pengsaa et al., THE EFFECTS OF THIOPHOSPHORIC ACID (UKRAIN) ON CERVICAL-CANCER, STAGE-IB BULKY, Drugs under experimental and clinical research, 18, 1992, pp. 69-72
This study was carried out to determine the clinical and immune respon
se of a stage IB voluminous uterine cervical cancer to thiophosphoric
acid alkaloid derivates from Chelidoniium majus L. (Ukrain). The drugs
were administered 10 mg intramuscularly every other day, for up to 10
injections. The two largest diameters and tumour volumes were measure
d and laboratory and immunological tests were performed before and aft
er Ukrain administration. The patients were then operated on with type
III Piver's radical hysterectomy. Three out of nine eligible cases ha
d partial responses while six cases remained stable. Decreased total B
lymphocytes and suppressor T lymphocytes were observed as well as inc
reased total numbers of T lymphocytes and helper T lymphocytes. There
was no single case of clinical or haematological toxicity apart from m
ild nausea. Two patients were treated with adjuvant radiotherapy due t
o lymphatic involvement and all nine patients were still alive at leas
t six months after follow-up.